Novo Holdings A/S 13D and 13G filings for 4D Molecular Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-20 5:12 pm Purchase | 2025-10-13 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Novo Holdings A/S | 3,175,000 6.800% | 3,175,000 (New Position) | Filing |